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Background: The objective of the study is to compare complication rates of laparoscopic nephrectomy and open
nephrectomy using a standardized classification method
Methods: We retrospectively included 843 patients from March 2006 to November 2012, of whom 88 had
laparoscopic radical nephrectomy (LRN), 526 had open radical nephrectomy (ORN), 42 had laparoscopic partial
nephrectomy (LPN), and 187 had open partial nephrectomy (OPN). A modified Clavien classification system was
applied to quantify complications of nephrectomy. Fisher’s exact or chi-square test were used to compare
complication rates between laparoscopic and open approaches.
Results: The overall complication rate was 19.31%, 30.04%, 35.71%, and 36.36% in LRN, ORN, LPN, and OPN,
respectively. More Grade II complications (odds ratio = 2.593, 95% CI 1.172 to 5.737, P = 0.010) and longer
postoperation hospital stay (9.2 days and 7.6 days, P < 0.001) were observed in ORN compared with LRN. In
multivariable analysis, surgical approach (LRN/ORN) (P = 0.036), age (P = 0.044), height (P = 0.020), systolic pressure
(P = 0.012), fasting blood glucose level (P = 0.032), and blood loss during operation (P = 0.011) were significant
predictors for grade II complications in radical nephrectomy. LPN had similar complication rates compared with OPN.
Conclusions: In conclusion, LRN had the advantages of less grade II complications and shorter postoperation hospital
stay than ORN. Older age and more blood loss during operation would also contribute to more grade II complications
in radical nephrectomy.
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Renal tumor is one of the most frequently diagnosed uro-
logical tumors, ranking eighth among all the tumors in the
United States in 2012 [1]. Laparoscopic technology was
applied in urological surgeries soon after it was put in
practice. In 1991, the first laparoscopic nephrectomy was
performed by Clayman and colleagues [2]. Since then, a
number of studies [3,4] have reported that laparoscopic
surgery offers several advantages over traditional open sur-
gery (such as alleviating postoperative pain, a decreased* Correspondence: haowen_jiang@126.com
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unless otherwise stated.length of hospital stay and earlier recovery), while achiev-
ing equivalent cancer control.
Besides the long-term outcome of nephrectomy, the
short-term postoperation outcome (mainly the compli-
cation rate) is also generally used to demonstrate the
quality of care which has been provided to the patient.
Several studies [4,5] reported that laparoscopic neph-
rectomy had similar complication rates to open neph-
rectomy. The Clavien classification system (CCS) has
been proposed as a mean of quantifying the complica-
tions of surgery [6]. It has recently been modified and
prospectively validated in a large patient cohort [7]. Few
studies have applied the modified CCS in urological sur-
geries. Also, no study in China has investigated theThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ized method. We conducted this study to investigate the
risk of complications in laparoscopic nephrectomy and
open nephrectomy in the Chinese population.
Methods
Patient source
After obtaining approval of the Institutional Review
Board of Huashan Hospital, Fudan University, Shanghai
China, a retrospective study of medical records from
March 2006 to November 2012 was performed to iden-
tify all patients who underwent radical or partial neph-
rectomy for presumed renal tumor. After reviewing
medical records and the patient information system, we
identified a total of 843 patients with detailed admission
information and clinical information, as well as ope-
rative, postoperative and pathological information. All
subjects were ethnic Han Chinese. Among them, 614
received radical nephrectomy (88 had laparoscopic rad-
ical nephrectomy (LRN); 526 had open radical nephrec-
tomy (ORN)) and 229 had partial nephrectomy (42 had
laparoscopic partial nephrectomy (LPN); 187 had open
partial nephrectomy (OPN)). Both open nephrectomy
and laparoscopic nephrectomy have been performed for
a long time in our hospital, open nephrectomy for more
than 50 years. Our department was the first to perform
laparoscopic surgeries in our hospital, and we have over
10 years experience performing laparoscopic nephrec-
tomy. In order to reduce potential bias, all 843 patients
we included received either radical nephrectomy or par-
tial nephrectomy via the transretroperitoneal approach
in the modified lateral decubitus position. Both LRN and
LPN were performed with four trocars (anterior axillary
line 2 cm above crista iliaca, mid-axillary line 2 cm
above crista iliaca, anterior axillary line 2 cm under the
costal margin, and posterior axillary line 2 cm under the
costal margin). In LRN, the excised kidney was taken
out through incision of the two holes above the crista
iliaca. In LPN, the excised tumor was taken out through
the hole of the mid-axillary line 2 cm above crista iliaca.
Written consent was given by the patients for their in-
formation to be stored in the hospital database and used
for research.
Patient characteristics
Patient characteristics were obtained mainly from elec-
tronic medical records in Huashan Hospital. Basic infor-
mation, such as height, weight, blood pressure, fasting
blood glucose level, medical history of hypertension and
diabetes, were collected on admission. Diabetes mellitus
was defined as pharmacological treatment for type 2
diabetes mellitus, elevated fasting plasma glucose level
(≥7.0 mmol/L), or elevated 2-hour postprandial plasma
glucose level (≥11.1 mmol/L) on admission. Hypertensionwas defined as pharmacological treatment for hypertension
or elevated blood pressure (≥140/90 mmHg) on admission.
Body mass index (BMI) was calculated as the ratio of the
patient weight (kg) divided by the square of the patient
height (m). Patients were divided into four groups based on
the recommendation from the World Health Organization
(WHO) [8] and Guidance of Obesity Control in China:
underweight, <18.5 kg/m2; normal, 18.5 to 23.9 kg/m2;
overweight, 24 to 27.9 kg/m2; obese, ≥28 kg/m2. Patho-
logical tumor size was mainly determined by imaging. For
those without detailed imaging information, the intra-
operative size was used [9]. Pathological profiles were
blindly determined by two independent pathologists ac-
cording to the 2004 WHO classification [10]. Information
about volume of blood loss and blood transfusion during
operation were collected from operation notes. Length of
postoperation stay was defined as the period from the day
when nephrectomy was performed to the day of discharge.
Length of operation time was defined as the period from
the beginning of incision to the end of wound closure.
Primary outcomes
The primary outcome that we assessed was post-
nephrectomy complications of patients. Patients were
followed-up until discharge. If patients were discharged
earlier, they would be followed-up for 30 days postopera-
tively. Operative characteristics and complications were
recorded in medical records. We identified specific
International Statistical Classification of Diseases and
Related Health Problems-9 codes for acute renal failure,
cardiac complications, wound complications, postopera-
tive infection, gastrointestinal complications, pulmonary
complications, thromboembolic complications, postopera-
tive hemorrhage, neurologic complications and miscel-
laneous technical complications related to surgery. Each
measure has been described previously by the Complica-
tions Screening Program [11].
In order to quantify surgical complication severity, we
applied the standardized method (modified CCS) 7 to
divide the complications into five major grades: Grade I,
any deviation from the normal intraoperative or postop-
erative course, including the need for pharmacologic
treatment other than antiemetics, antipyretics, analgesics,
diuretics, electrolytes, or physiotherapy; Grade II, complica-
tions needing only the use of intravenous medications, total
intravenous nutrition, or blood transfusion; Grade IIIa,
complications needing surgical, endoscopic, or radiologic
intervention under local anesthesia; Grade IIIb, complica-
tions calling for surgical, endoscopic, or radiologic interven-
tion under general anesthesia; Grade IVa, life-threatening
complications requiring ICU management - single organ
dysfunction; Grade IVb, life-threatening complications re-
quiring ICU management - multi-organ dysfunction; Grade
V, death of the patient (Table 1). Grade I and Grade II were
Table 1 Modified Clavien classification system for surgical
complications
Low grade
Grade I Any deviation from the normal intraoperative or
postoperative course, including the need for
pharmacologic treatment other than antiemetics,
antipyretics, analgesics, diuretics, electrolytes,
or physiotherapy
Grade II Complications needing only the use of intravenous
medications, total intravenous nutrition,
or blood transfusion
High grade
Grade IIIa Complications needing surgical, endoscopic,
or radiologic intervention under local anesthesia
Grade IIIb Complications needing surgical,
endoscopic, or radiologic intervention
under general anesthesia
Grade IVa Life-threatening complications requiring
ICU management - single organ
dysfunction (including hemodialysis)
Grade IVb Life-threatening complications requiring
ICU management - multi-organ dysfunction
Grade V Death of the patient
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were defined as high grade.
Statistical analysis
Patient age, tumor size, length of postoperation hospital
stay, blood loss during operation, and blood transfusion
during operation were expressed as mean ± SD, and two-
way analysis of variance was used for comparison among
all the groups for parametric analysis. Nonparametric
data, such as sex (male/female), location of tumor
(right/left), cancer category, and complication rates
were evaluated using Fisher’s exact or chi-square ana-
lyses. We used multivariable logistic regression models
to estimate the association between age (<40, 40–49,
50–59, 60–69, 70–79, and ≥80 years), gender (male/fe-
male), hypertension (yes/no), diabetes (yes/no), BMI
(underweight/normal/overweight/obese), tumor size, vol-
ume of blood loss during operation, and length of oper-
ation time, as well as volume of blood transfusion during
operation and our primary outcomes. We specified each
outcome (complication) as a binary (yes/no) variable. All
statistical testing was two-sided, performed using SPSS
version 19.0 for Windows (SPSS Inc., Chicago, IL, USA);
P < 0.05 was considered statistically significant.
Results
Among the 526 patients who had ORN, five patients were
initially scheduled for LRN and converted to ORN (three
cases were due to peri-renal adhesions and the other two
cases were due to bleeding of the renal vein), and 12 pa-
tients were initially scheduled for OPN and converted toORN (10 cases were due to urinary collecting system dam-
aged during operation and the other two cases were due
to bleeding of the renal wound surface). Among the 187
patients who had OPN, two patients were initially sched-
uled for LPN and converted to OPN (due to bleeding of
the renal wound surface). Basic information for patients
are shown in Table 2. No statistical significance in patient
age, gender (male/female), location of tumor (right/left),
blood loss or blood transfusion during operation was ob-
served among the patients receiving LRN and ORN, nor
for patients receiving LPN and OPN. Various types of renal
tumors were observed, including angioleiomyolipoma,
clear cell renal cell carcinoma, papillary renal cell carcin-
oma, chromophobe renal cell carcinoma, renal medullary
carcinoma, collecting duct carcinoma, Xp11 translocation
renal cell carcinoma, mucinous tubular and spindle cell
carcinoma, sarcomatoid renal cell carcinoma, oncocytoma,
metanephric adenoma, cystic nephroma, multilocular cys-
tic nephroma, synovial sarcoma (monophasic), carcinoid
tumor, primitive neumectodermai tumor, liposarcoma,
pleomorphic sarcoma, adult rhabdomyosarcoma, squa-
mous cell carcinoma, non-Hodgkin's lymphoma, solitary
fibrous tumor, and inflammatory pseudotumor. A higher
rate of angioleiomyolipoma was observed in partial neph-
rectomy than radical nephrectomy. Patients who re-
ceived ORN had a larger tumor size (5.3 ± 2.3 cm
versus 4.6 ± 1.9 cm, P = 0.002), and 1.6 days longer
postoperation hospital stay (9.2 days versus 7.6 days,
P < 0.001) compared with those who received LRN.
Laparoscopic nephrectomy, including both LRN and
LPN, had a longer operation time than open nephrec-
tomy. The operation time of LPN was significantly
27.9 minutes longer than that for OPN (154.1 ±
141.2 minutes versus 126.2 ± 91.3 minutes, P = 0.034).
Table 3 illustrates the overall complication rates and
complication rates for each category, as well as every spe-
cific complication rate. The overall complication rate was
19.31%, 30.04%, 35.71%, and 36.36% with LRN, ORN,
LPN, and OPN, respectively. The non-complication rate
for ORN was significantly lower than that for LRN (odds
ratio = 0.867, 95% CI 0.772 to 0.974, P = 0.039). Complica-
tion rates for each category and every specific complication
rate were similar among radical and partial nephrectomy.
Gastrointestinal complications were most common among
all the postoperation complications (6.82% in LRN, 10.08%
in ORN, 11.90% in LPN, and 13.90% in OPN). Two pa-
tients (0.038%) died after receiving ORN.
Table 4 shows the standardized complication rates
among the four surgical approaches by using the modified
CCS. Low-grade complication rates in ORN were moder-
ately higher than that in LRN (27.19% versus 18.18%, P =
0.074). More Grade II complications were observed with
ORN compared to LRN (odds ratio = 2.593, 95% CI 1.172
to 5.737, P = 0.010). No significant difference in high-
Table 2 Patient basic characteristics by surgical approach
Radical nephrectomy Partial nephrectomy
LRN ORN LPN OPN
Patient numbers 614 229
88 526 42 187
Age (years) 56.5 ± 13.3 57.32 ± 12.4 53.2 ± 14.0 51.5 ± 13.2
Male/female 55/33 341/185 19/23 119/68a
Right/left 49/39 263/263 21/21 89/98
Category of cancer (n) (%) (n) (%) (n) (%) (n) (%)
Angioleiomyolipoma 2 2.27 28 5.32 14 33.33 50 26.74
Malignant renal cell tumors
Clear cell renal cell carcinoma 67 76.14 399 75.86 21 50.00 110 58.82
Papillary renal cell carcinoma 5 5.68 19 3.61 3 7.14 8 4.28
Clear cell renal cell carcinoma combined
with papillary renal cell carcinoma
0 0.00 5 0.95 1 2.38 0 0.00
Chromophobe renal cell carcinoma 4 4.55 13 2.47 0 0.00 5 2.67
Renal medulary carcinoma 1 1.14 0 0.00 0 0.00 0 0.00
Collecting duct carcinoma 0 0.00 3 0.57 0 0.00 0 0.00
Xp11 translocation renal cell carcinoma 1 1.14 0 0.00 0 0.00 0 0.00
Mucinous tubular and spindle cell carcinoma 0 0.00 1 0.19 0 0.00 0 0.00
Renal cell carcinoma unclassified
Sarcomatoid renal cell carcinoma 0 0.00 1 0.19 0 0.00 1 0.53
Renal cell carcinoma 5 5.68 33 6.27 0 0.00 6 3.21
Benign renal cell tumors
Oncocytoma 2 2.27 6 1.14 1 2.38 2 1.07
Metanephric tumors
Metanephric adenoma 0 0.00 0 0.00 1 2.38 0 0.00
Mixed mesenchymal and epithelial tumors
Cystic nephroma 0 0.00 2 0.38 0 0.00 1 0.53
Multilocular cystic nephroma 0 0.00 5 0.95 0 0.00 4 2.14
Synovial sarcoma (monophasic) 0 0.00 1 0.19 0 0.00 0 0.00
Neuroendocrine tumors
Carcinoid tumor 0 0.00 1 0.19 0 0.00 0 0.00
Primitive neumectodermai tumor 0 0.00 1 0.19 0 0.00 0 0.00
Mesenchymal tumors
Liposarcoma 0 0.00 1 0.19 0 0.00 0 0.00
Pleomorphic sarcoma 0 0.00 1 0.19 0 0.00 0 0.00
Adult rhabdomyosarcoma 0 0.00 1 0.19 0 0.00 0 0.00
Squamous cell carcinoma 1 1.14 1 0.19 0 0.00 0 0.00
Non-Hodgkin's lymphoma 0 0.00 1 0.19 1 2.38 0 0.00
Other tumors
Solitary fibrous tumor 0 0.00 2 0.38 0 0.00 0 0.00
Inflammatory pseudotumor 0 0.00 1 0.19 0 0.00 0 0.00
Tumor size (cm) 4.6 ± 1.9 5.3 ± 2.3b 3.3 ± 2.2 3.6 ± 1.4
Length of postoperation hospital stay (days) 7.6 ± 2.4 9.2 ± 3.9c 8.5 ± 3.1 9.3 ± 3.8
Length of operation time (minutes) 133.7 ± 101.4 120.3 ± 78.8 154.1 ± 141.2 126.2 ± 91.3d
Blood loss during operation (ml) 235.9 ± 411.9 232.1 ± 379.5 191.1 ± 166.0 231.5 ± 222.5
Blood transfer during operation (ml) 67.4 ± 224.6 86.4 ± 322.6 19.0 ± 86.2 36.4 ± 115.3
aP = 0.028; bP = 0.002; cP < 0.001; dP = 0.034. LPN, laparoscopic partial nephrectomy; LRN, laparoscopic radical nephrectomy; OPN, open partial nephrectomy;
ORN, open radical nephrectomy.
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Table 3 Complication rates by surgical approach
Radical nephrectomy Partial nephrectomy
LRN ORN LPN OPN
n % n % n % n %
Total patient number 88 526 42 187
Non-complication 71 80.68 368 69.96 27 64.29 119 63.64
Genitourinary 1 1.14 7 1.33 0 0.00 0 0.00
Acute renal failure 1 1.14 7 1.33 0 0.00 0 0.00
Wound 0 0.00 7 1.33 0 0.00 6 3.21
Infection 0 0.00 1 0.19 0 0.00 1 0.53
Subcutaneous hydrops 0 0.00 6 1.14 0 0.00 5 2.67
Infectious 1 1.14 13 2.47 0 0.00 3 1.60
Urinary tract infection 0 0.00 3 0.57 0 0.00 1 0.53
Fever of unknown origin 1 1.14 8 1.52 0 0.00 2 1.07
Sepsis 0 0.00 2 0.38 0 0.00 0 0.00
Gastrointestinal 6 6.82 53 10.08 5 11.90 26 13.90
Hiccup 0 0.00 2 0.38 0 0.00 0 0.00
Stress ulcer 0 0.00 14 2.66 2 4.76 7 3.74
Small-bowel obstruction 0 0.00 3 0.57 0 0.00 2 1.07
Constipation 3 3.41 15 2.85 1 2.38 5 2.67
Gastrointestinal bleeding 0 0.00 1 0.19 0 0.00 4 2.14
Emesis 3 3.41 13 2.47 2 4.76 6 3.21
Biliary colic 0 0.00 0 0.00 0 0.00 1 0.53
Pancreatitis 0 0.00 1 0.19 0 0.00 0 0.00
Pancreatic fistula 0 0.00 4 0.76 0 0.00 1 0.53
Cardiac 4 4.55 20 3.80 1 2.38 9 4.81
Arrhythmia 1 1.14 6 1.14 0 0.00 2 1.07
Myocardial infarction 0 0.00 2 0.38 0 0.00 0 0.00
Congestive heart failure 0 0.00 1 0.19 0 0.00 0 0.00
Hypertension 3 3.41 11 2.09 1 2.38 7 3.74
Pulmonary 2 2.27 10 1.90 4 9.52 8 4.28
Pneumonia/pneumonitis 1 1.14 4 0.76 2 4.76 2 1.07
Pneumothorax 0 0.00 1 0.19 0 0.00 2 1.07
Respiratory distress 0 0.00 1 0.19 1 2.38 1 0.53
Pleural effusion 1 1.14 2 0.38 1 2.38 3 1.60
Atelectasis 0 0.00 2 0.38 0 0.00 0 0.00
Thromboembolic 0 0.00 1 0.19 0 0.00 0 0.00
Deep venous thrombosis 0 0.00 1 0.19 0 0.00 0 0.00
Bleeding 1 1.14 11 2.09 3 7.14 7 3.74
Perinephric hematoma 0 0.00 0 0.00 1 2.38 0 0.00
Other postoperative hemorrhage 0 0.00 7 1.33 0 0.00 3 1.60
Anemia 1 1.14 4 0.76 2 4.76 4 2.14
Neurologic 0 0.00 3 0.57 1 2.38 1 0.53
Cerebrovascular event 0 0.00 1 0.19 1 2.38 1 0.53
Neuropathy 0 0.00 1 0.19 0 0.00 0 0.00
Syncope 0 0.00 1 0.19 0 0.00 0 0.00
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Table 3 Complication rates by surgical approach (Continued)
Miscellaneous 2 2.27 33 6.27 1 2.38 8 4.28
Anaphylaxis 1 1.14 9 1.71 0 0.00 0 0.00
Chylous leak 0 0.00 6 1.14 0 0.00 0 0.00
Gout 0 0.00 1 0.19 0 0.00 2 1.07
Hyponatremia 0 0.00 2 0.38 0 0.00 1 0.53
Shock 0 0.00 0 0.00 0 0.00 1 0.53
Hypoalbuminemia 1 1.14 15 2.85 1 2.38 4 2.14
Death 0 0.00 2 0.38 0 0.00 0 0.00
LPN, laparoscopic partial nephrectomy; LRN, laparoscopic radical nephrectomy; OPN, open partial nephrectomy; ORN, open radical nephrectomy.
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and partial nephrectomy.
Univariable analyses of Grade II complications in rad-
ical nephrectomy are shown in Table 5. The association
between Grade II complication rate and age, gender, lo-
cation of tumor, BMI, height, weight, systolic pressure,
diastolic pressure, hypertension status, fasting blood glu-
cose level, diabetes status, tumor size, length of oper-
ation time, and blood loss during operation, as well as
blood transfusion during operation were examined sep-
arately. BMI (P = 0.035), blood loss during operation
(P < 0.001), and blood transfusion during operation (P =
0.001) were significant predictors for Grade II complica-
tions in radical nephrectomy. These three variables and
those with a P value less than 0.500 were included in
multivariable analysis. As shown in Table 5, surgical ap-
proach (LRN/ORN) (P = 0.036), age (P = 0.044), height
(P = 0.020), systolic pressure (P = 0.012), fasting blood
glucose level (P = 0.032), and blood loss during operation
(P = 0.011) were significant predictors for Grade II com-
plications in radical nephrectomy.Table 4 Standardized complication rates by surgical approach
Radical nephrectomy
LRN ORN
Total number 88 526
n % n %
Non-complication 71 80.68 368 69.96
Low grade 16 18.18 143 27.19
Grade I 10 11.36 50 9.51
Grade II 6 6.82 93 17.68
High grade 1 1.14 15 2.85
Grade IIIa 0 0.00 6 1.14
Grade IIIb 0 0.00 0 0.00
Grade IVa 1 1.14 7 1.33
Grade IVb 0 0.00 0 0.00
Grade V 0 0.00 2 0.38
*Fisher’s exact test. aOdds ratio = 0.867, 95% CI 0.772 to 0.974; bodds ratio = 2.593, 9
radical nephrectomy; NA, not applicable; OPN, open partial nephrectomy; ORN, opeDiscussion
With the increased use of laparoscopy in urological sur-
geries, numerous studies have documented the benefits
of minimally invasive surgery. We are the first in China
to compare the complication rates of laparoscopic and
open nephrectomy using standardized reporting meth-
odology. In our study, as shown in Table 3, we found
that the non-complication rate with ORN was signifi-
cantly lower than that with LRN (69.96% versus 80.68%,
P = 0.039). Similar findings were reported by Tan and
colleagues 12 in 2011. With respect to LPN, we did not
find any significantly lower complication rate compared
to OPN. This might be limited by the relatively small
patient population. In addition, as shown in Table 2,
patients who received ORN had significantly longer
postoperation hospital stay (9.2 days versus 7.6 days, P <
0.001). This suggests that patients who received ORN
need more postoperation recovery time. However, the
complication rates for each category and every specific
complication rate did not seem to be decreased either in
LRN or in LPN.Partial nephrectomy
LPN OPN
42 187
P n % n % P
0.039a 27 64.29 119 63.64 0.973
0.074 15 35.71 61 32.62 0.700
0.587 4 9.52 20 10.70 1.000*
0.010b 11 26.19 41 21.93 0.551
0.714* 0 0.00 7 3.74 0.355*
0.601* 0 0.00 6 3.21 0.596*
NA 0 0.00 1 0.53 1.000*
1.000* 0 0.00 0 0.00 NA
NA 0 0.00 0 0.00 NA
1.000* 0 0.00 0 0.00 NA
5% CI 1.172 to 5.737. LPN, laparoscopic partial nephrectomy; LRN, laparoscopic
n radical nephrectomy.
Table 5 Univariable and multivariable analysis of Grade II








Body mass index 0.035 0.230
Height 0.12 0.020
Weight 0.672
Systolic pressure 0.052 0.012
Diastolic pressure 0.658
Hypertension status 0.225 0.441
Fasting blood glucose level 0.253 0.032
Diabetes status 0.365 0.524
Tumor size 0.326 0.170
Length of operation time 0.522
Blood loss during operation <0.001 0.011
Blood transfusion during operation 0.001 0.340
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mainly limited to low–grade complications. Patients
who received ORN had a moderately higher risk of de-
veloping low-grade complications. With further exam-
ination, we find that increased Grade II complication
rate was the main factor contributing to the higher
complication rate in ORN. In other words, LRN might
not reduce the high-grade complication rate. Since we
included patients in our study from 2006, open and
laparoscopic nephrectomy technologies are well practiced
and established. Furthermore, improved anesthesia tech-
nologies and postoperative monitoring also help to
prevent high-grade complications. However, two pa-
tients (0.38%) died after ORN. The mortality rate was
relatively low compared with other studies [12]. This
was also a benefit of the improvement in the related
technologies.
Using multivariable analysis, patient age contributed
significantly to higher Grade II complication rates. Simi-
lar findings were also reported by Lowrance and col-
leagues. They found that age was significantly associated
with a small increase in the risk of complications (odds
ratio for 10-year increase in age 1.17, 95% CI 1.04 to
1.32, P = 0.009). However, in another study by Reifsnyder
and colleagues 5, age was not a significant predictor for
more overall complications. In both Lowrance and col-
leagues’ [13] and our studies, age was taken into the ana-
lysis as an ordered categorical variable rather than a
continuous variable. This is more rational and clinicallymore meaningful than investigating how much increased
risk would be present if the patient was 1 year older. It
helps urologists understand the influence of age on post-
nephrectomy complications and explain it to the patients.
Blood loss during the operation was another signifi-
cant predictor for higher Grade II complications. Al-
though we found that LRN did not have less blood loss
during the operation than ORN, more blood loss would
result in more post-nephrectomy complications. This
finding was consistent with the analysis of Reifsnyder
and colleagues 5 showing that more blood loss predicted
more overall complications. Higher systolic pressure and
fasting blood glucose level would also contribute to more
Grade II complications. This suggests that hypertension
and diabetes might play an important role in post-
nephrectomy complications. However, neither hyperten-
sion nor diabetes status was a significant predictor in our
multivariable analysis. Further study focusing on the effect
of hypertension and diabetes on post-nephrectomy com-
plications is needed.
Laparoscopic nephrectomy had a longer operation time
than that of open nephrectomy, accompanied by a rela-
tively lower complication rate. However, it could not be
inferred that a longer operation time was associated with
lower complication rate solely based on this. Though offer-
ing a better operation vision, laparoscopic nephrectomy
could take a considerably longer time to perform than
open nephrectomy. Laparoscopic techniques need rela-
tively skilled experience and beginners usually take a longer
time. Besides, laparoscopic nephrectomy requires more
delicate and precise operation movements which partly
contribute to the longer operation time. We cannot jump
to the conclusion that a longer operation time would lead
to a lower complication rate only according to superficial
data. Delicate and precise operation movements not only
partly result in a longer operation time, but also a lower
complication rate.
Although the average tumor size in both ORN and LRN
was greater than 4 cm, we observed that the tumor size in
ORN was significantly larger than that in LRN (Table 2).
We further examined whether a bigger tumor size might
contribute to a higher complication rate using univariable
and multivariable analysis. Tumor size was not a signifi-
cant predictor for complication rates with radical nephrec-
tomy. The difference in tumor size between ORN and
LRN may be caused by the relatively small sample size for
LRN; in addition, we did not group patients randomly.
In China, National Health Insurance does not cover all
surgeries. A large proportion of the cost of laparoscopic
surgeries, including laparoscopic nephrectomy, is at the
patient's own expense. Patients have to pay for the trocars,
ultrasonic scalpel, hemolocks, and so forth. Thus we were
not able to randomize the patients into a laparoscopic
nephrectomy group and an open nephrectomy group. We
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made by the patients themselves. This non-random selec-
tion has potential bias, which might contribute to the
significant difference in tumor size.
We have also observed that wound complications, in-
cluding wound infection and subcutaneous hydrops, only
appeared in the open nephrectomy. Previous studies have
reported that wound infection in laparoscopic nephrec-
tomy is quite rare [14,15]. Open nephrectomy is character-
ized by a long incision (20 cm), while wound length is
significantly shorter in laparoscopic nephrectomy (LRN
usually has a 10-cm incision; the wound length is even
shorter in LPN). Besides better wound cosmetics and less
wound pain, laparoscopic nephrectomy had a lower risk of
wound infection and subcutaneous hydrops because less
damage was made and less wound surface was exposed.
Conclusion
In conclusion, we found that LRN had the advantages of
less Grade II complications and shorter postoperation
hospital stay than ORN. There was no significant differ-
ence in complication rates between LPN and OPN. Older
age and more blood loss during the operation also
contribute to more Grade II complications in RN. Further-
more, hypertension and diabetes status pose potential
risks for complications.
There are several limitations of this study to be consid-
ered. First, the sample size of the laparoscopic nephrec-
tomy group was relatively small. This limitation was due to
the fact that the cost of laparoscopic nephrectomy is rela-
tively higher than open nephrectomy in China and is not
all covered by National Health Insurance. A large portion
of patients could not afford laparoscopic nephrectomy and
chose open nephrectomy. We still enrolling subjects and
further investigating the difference in complications be-
tween laparoscopic and open nephrectomy. Second, our
study focused on the post-nephrectomy complications in
the early stage. In our new study, we plan to prolong the
follow-up and investigate complications of laparoscopic
and open nephrectomy for longer periods.
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